AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Corsita M 50mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Medley Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Corsita M 50mg/1000mg Tablet SR

Diabetica Duo 50mg/1000mg Extended-Release Tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, and may lower the risk of cardiovascular events. Diabetica Duo may be used alone or with other diabetes treatments. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician's guidance. Continued adherence to your prescribed diet and exercise plan is crucial for diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when used with insulin or sulfonylureas; learn how to identify and manage this. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should seek medical advice prior to use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its blood sugar-lowering effects. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Corsita M 50mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Corsita M 50mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Corsita M 50mg/1000mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Corsita M 50mg/1000mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Corsita M 50mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Corsita M 50mg/1000mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Corsita M 50mg/1000mg Tablet SR works:

Corsita M 50mg/1000mg Extended-Release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Corsita M 50mg/1000mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Corsita M 50mg/1000mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Corsita M 50mg/1000mg tablets are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Corsita M 50mg/1000mg SR tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Corsita M 50mg/1000mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

The extended-release Corsita M 50mg/1000mg tablet is likely unsuitable for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take Corsita M 50mg/1000mg Tablet SR :

Should you forget a Corsita M 50mg/1000mg SR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed amount.

Facts to Know About Corsita M 50mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Corsita M 50mg/1000mg Tablet SR

Corsita M 50mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Corsita M 50mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes including balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Corsita M 50mg/1000mg SR tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Corsita M 50mg/1000mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Corsita M 50mg/1000mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Corsita M 50mg/1000mg Tablet SR. This occurs due to elevated blood lactic acid levels. Because it's rare but potentially life-threatening, Corsita M is avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin immediately and seek urgent medical attention.
Corsita M 50mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Corsita M 50mg/1000mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Corsita M 50mg/1000mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Corsita M 50mg/1000mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Corsita M 50mg/1000mg Tablet SR. This condition, caused by excessive blood lactic acid, is rare but more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Corsita M 50mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Corsita M 50mg/1000mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Corsita M 50mg/1000mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Corsita M 50mg/1000mg Tablet SR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Corsita M 50mg/1000mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Corsita M 50mg/1000mg SR can cause lactic acidosis (MALA—Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Corsita M 50mg/1000mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Corsita M 50mg/1000mg Tab...
139